News

Kurin, Inc. Reports Record Q3 Sales

October 18, 2021

Kurin, Inc. announces UK clinical study results showing significant decrease in blood culture contaminations with the Kurin Lock™

October 5, 2021

Kurin, Inc. Reports Record Sales Month

August 10, 2021

Kurin, Inc. announces results on Kurin® efficacy from Oishei Children’s Hospital with zero blood culture contaminations

July 21, 2021

Kurin, Inc. Announces Removal of Magnolia Patent Infringement Lawsuit Trial Date

March 23, 2021

Kurin, Inc. announces peer-reviewed publication on Kurin® efficacy from Central Texas Veterans Health Care System

January 19, 2021

Kurin, Inc. honored by MD Tech Review in annual listing of top Infection Control solutions

December 24, 2020

Kurin, Inc. Named to Inc.’s Inaugural Best in Business List in the Prosperous and Thriving Category

December 8, 2020

Kurin, Inc. Receives Allowance from United States Patent and Trademark Office of Additional Claims to its Innovative Blood Culture Collection Device.

November 17, 2020

Kurin, Inc. Reports Record Revenues

October 6, 2020

Kurin, Inc. Receives Supplier Horizon Award from Premier Inc.

September 29, 2020

Kurin, Inc. continues sales growth with record month.

July 29, 2020

Kurin, Inc. Announces Agreement with Intalere for Kurin Lock to impact contaminated blood cultures

June 30, 2020

Kurin, Inc. Announces Agreement with Vizient for Kurin Lock to help reduce contaminated blood cultures

April 21, 2020

Kurin, Inc. receives FDA 510k clearance for its push-button needle

February 25, 2020

Kurin, Inc. Announces Hire of EVP Operations Amid Record Growth

January 22, 2020

Kurin, Inc. Reports Record Third Quarter Revenues

October 2, 2019

Kurin, Inc. receives CE Mark for its novel Kurin Lock®

May 21, 2019

Kurin Inc. Responds to Allegations Published by Magnolia Medical Regarding Patent Infringement

March 14, 2019

Kurin, Inc. CEO Addresses Patent Infringement Lawsuit Brought by Magnolia Medical

February 12, 2019
1 2

ML-021 Rev A